Stavropoulos Andreas, Kostopoulos Lambros, Mardas Nicolaos, Karring Thorkild
Department of Periodontology and Oral Gerontology, Faculty of Health Sciences, Royal Dental College, University of Aarhus, Vennelyst Boulevard 9, 8000 Aarhus C, Denmark.
Clin Implant Dent Relat Res. 2003;5(3):184-92. doi: 10.1111/j.1708-8208.2003.tb00201.x.
There are results suggesting that differences regarding bone-inducing potential, in terms of amount and/or rate of bone formation, exist between demineralized bone matrices (DBMs) of different embryonic origins.
The aim of the present study was to examine whether the embryonic origin of DBM affects bone formation when used as an adjunct to guided tissue regeneration (GTR).
Endomembranous (EM) and endochondral (ECH) DBMs were produced from calvarial and long bones of rats, respectively. Prior to the study the osteoinductive properties of the DBMs were confirmed in six rats following intramuscular implantation. Following surgical exposure of the mandibular ramus, a rigid hemispheric Teflon capsule loosely packed with a standardized quantity of DBM was placed with its open part facing the lateral surface of the ramus in both sides of the jaw in 30 rats. In one side of the jaw, chosen at random, the capsule was filled with EM-DBM, whereas in the other side ECH-DBM was used. Groups of 10 animals were sacrificed after healing periods of 1, 2, and 4 months, and undecalcified sections of the capsules were produced and subjected to histologic analysis and computer-assisted planimetric measurements.
During the experiment increasing amounts of newly formed bone were observed inside the capsules in both sides of the animals' jaws. Limited bone formation was observed in the 1- and 2-month specimens, but after 4 months of healing, the newly formed bone in the ECH-DBM grafted sides occupied 59.1% (range 45.6-74.7%) of the area created by the capsule versus 46.9% (range 23.0-64.0%) in the EM-DBM grafted sides (p =.01).
It is concluded that the embryonic origin of DBM influences bone formation by GTR and that ECH-DBM is superior to EM-DBM.
有研究结果表明,不同胚胎来源的脱矿骨基质(DBM)在骨诱导潜力方面,即在骨形成的量和/或速率上存在差异。
本研究旨在探讨DBM的胚胎来源在作为引导组织再生(GTR)辅助材料使用时是否会影响骨形成。
分别从大鼠颅骨和长骨制备膜内成骨(EM)和软骨内成骨(ECH)的DBM。在研究前,通过肌肉内植入在6只大鼠中证实了DBM的骨诱导特性。在30只大鼠的下颌支手术暴露后,将一个刚性半球形聚四氟乙烯胶囊松散地填充标准量的DBM,其开口部分朝向颌骨两侧下颌支的外侧表面放置。在颌骨的一侧随机选择,胶囊填充EM-DBM,而在另一侧使用ECH-DBM。在1、2和4个月的愈合期后,每组10只动物被处死,制作胶囊的不脱钙切片并进行组织学分析和计算机辅助平面测量。
在实验过程中,在动物颌骨两侧的胶囊内观察到新形成骨的量不断增加。在1个月和2个月的标本中观察到有限的骨形成,但在愈合4个月后,ECH-DBM移植侧新形成的骨占胶囊所形成面积的59.1%(范围45.6 - 74.7%),而EM-DBM移植侧为46.9%(范围23.0 - 64.0%)(p = 0.01)。
得出结论,DBM的胚胎来源影响GTR的骨形成,且ECH-DBM优于EM-DBM。